1. Cell Mol Life Sci. 2023 Mar 10;80(4):85. doi: 10.1007/s00018-023-04725-8.

Correction: An oncogene addiction phosphorylation signature and its derived 
scores inform tumor responsiveness to targeted therapies.

Orlando E(#)(1)(2), Medo M(#)(1)(2), Bensimon A(3), Quintin A(1)(2), Riedo 
R(1)(2), Roth SM(1)(2), Riether C(4)(5), Marti TM(6)(7), Aebersold DM(1)(2), 
Medová M(#)(1)(2), Aebersold R(#)(8)(9), Zimmer Y(#)(10)(11).

Author information:
(1)Department of Radiation Oncology, Inselspital, Bern University Hospital and 
University of Bern, Bern, Switzerland.
(2)Department for BioMedical Research, Radiation Oncology, University of Bern, 
MEM-E807, Murtenstrasse 35, 3008, Bern, Switzerland.
(3)Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, 
HPM H25, Otto-Stern-Weg 3, 8093, Zurich, Switzerland.
(4)Tumorimmunology, Department for BioMedical Research, University of Bern, 
Bern, Switzerland.
(5)Department of Medical Oncology, Inselspital, University Hospital and 
University of Bern, 3010, Bern, Switzerland.
(6)Thoracic Surgery, Department for BioMedical Research, University of Bern, 
Bern, Switzerland.
(7)Division of General Thoracic Surgery, Inselspital Bern University Hospital, 
Bern, Switzerland.
(8)Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, 
HPM H25, Otto-Stern-Weg 3, 8093, Zurich, Switzerland. 
aebersold@imsb.biol.ethz.ch.
(9)Faculty of Science, University of Zürich, Zurich, Switzerland. 
aebersold@imsb.biol.ethz.ch.
(10)Department of Radiation Oncology, Inselspital, Bern University Hospital and 
University of Bern, Bern, Switzerland. yitzhak.zimmer@insel.ch.
(11)Department for BioMedical Research, Radiation Oncology, University of Bern, 
MEM-E807, Murtenstrasse 35, 3008, Bern, Switzerland. yitzhak.zimmer@insel.ch.
(#)Contributed equally

Erratum for
    Cell Mol Life Sci. 2022 Dec 10;80(1):6. doi: 10.1007/s00018-022-04634-2.

DOI: 10.1007/s00018-023-04725-8
PMCID: PMC9998563
PMID: 36894640